EXECUTIVE FUNCTION DEFICITS AND GLUTAMATERGIC PROTEIN ALTERATIONS IN A PROGRESSIVE 1-METHYL1-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MOUSE MODEL OF PARKINSON’S DISEASE

Changes within executive function are at the root of most cognitive problems associated with Parkinson’s disease (PD). Because dopaminergic treatment does not necessarily alleviate deficits in executive function, it has been hypothesized that dysfunction of other neurotransmitters/systems besides do...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurosci Res
Main Authors: Pflibsen, Lacey, Stang, Katherine A., Sconce, Michelle D., Wilson, Vanessa B., Hood, Rebecca L., Meshul, Charles K., Mitchell, Suzanne H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4618105/
https://ncbi.nlm.nih.gov/pubmed/26332770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jnr.23638
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados